Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency. [electronic resource]
Producer: 20110523Description: 726-36 p. digitalISSN:- 1945-7197
- Administration, Oral
- Alendronate -- therapeutic use
- Biomarkers
- Bone Density -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Calcitriol -- blood
- Circadian Rhythm -- physiology
- Collagen Type I -- metabolism
- Cyclic AMP -- urine
- Drug Therapy, Combination
- Female
- Human Growth Hormone -- deficiency
- Humans
- Male
- Middle Aged
- Parathyroid Hormone -- urine
- Peptides
- Phosphates -- administration & dosage
- Recombinant Proteins
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.